---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-012701"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:04:10.424309+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio regains Nasdaq minimum bid price compliance after reverse split

## Summary
- Received Nasdaq notice on March 20, 2026 confirming compliance with Listing Rule 5450(a)(1).
- Compliance achieved via 1-for-50 reverse stock split of common stock effective March 6, 2026.
- Nasdaq matter now closed; no further delisting risk from this requirement.

## SEC filing metadata
- accession: 0001493152-26-012701
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315226012701/0001493152-26-012701-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315226012701/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-012701
- JSON: https://secwatch.observer/filing/0001493152-26-012701.json
- Plain text: https://secwatch.observer/filing/0001493152-26-012701.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.